Clinical perspective on the clinical pharmacogenetics implementation consortium updated 2014 guidelines for CYP2D6 and codeine

Clinical Chemistry

Volumn 61, Issue 2, 2015, Pages 319-321

  Nicholson, Wayne T ^a   Formea, Christine M ^a  

^a Mayo Clinic College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; BUPRENORPHINE; CODEINE; CYTOCHROME P450 2D6; FENTANYL; HYDROCODONE; HYDROMORPHONE; METHADONE; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; OXYCODONE; OXYMORPHONE; PARACETAMOL; TRAMADOL; NARCOTIC ANALGESIC AGENT;

ANALGESIA; CANCER PAIN; CHRONIC PAIN; DRUG DOSAGE FORM; DRUG FATALITY; DRUG FORMULATION; DRUG METABOLISM; DRUG SAFETY; HUMAN; MUSCULOSKELETAL PAIN; NONHUMAN; PHARMACOGENETICS; PHARMACOGENOMICS; PHENOTYPE; PRACTICE GUIDELINE; REVIEW; TOOTH PAIN; GENETICS; METABOLISM; PAIN;

ANALGESICS, OPIOID; CODEINE; CYTOCHROME P-450 CYP2D6; HUMANS; PAIN; PAIN MANAGEMENT; PHARMACOGENETICS; PRACTICE GUIDELINES AS TOPIC;

EID: 84921828925     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2014.226795     Document Type: Review

References (4)

1. Crews KR, Gaedigk A, Dunnenberger HM, Leeder JS, Klein TE, Caudle KE, et al. Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update. Clin Pharmacol Ther 2014;95: 376-82.
2. Vargas-Schaffer G. Is the WHO analgesic ladder still valid? Twenty-four years of experience. Can Fam Physician 2010;56:514-7.
3. Centers for Disease Control and Prevention (CDC). Vital signs: risk for overdose from methadone used for pain relief-United States, 1999-2010. MMWR Morb Mortal Wkly Rep. 2012;61: 493-7.
4. Bartholow M. Top 200 Drugs of 2012. Pharmacy Times. http:// www.pharmacytimes.com/publications/issue/ 2013/July2013/Top-200-Drugs-of-2012 (Accessed June 2014)